GAL (Galanin) Gene: Structure, Function, and Clinical Significance

A comprehensive biomedical overview of the GAL gene, its protein product galanin, associated diseases, expression patterns, and mutations.

Gene Information Card

Symbol GAL
Full Name galanin
Gene Type protein-coding
Chromosomal Location 11q13.2
NCBI Gene ID 51083 ncbi.nlm.nih.gov/gene/51083
Ensembl ID ENSG00000069482
UniProt ID P22466
OMIM ID 137035
HGNC ID 4114
Aliases GALN, GMAP

Description

The GAL gene encodes preprogalanin, a precursor protein that is proteolytically processed to produce galanin, a 30-amino acid neuropeptide, and other peptides such as galanin message-associated peptide (GMAP). Galanin is widely expressed in the central and peripheral nervous systems and regulates various physiological processes including pain modulation, cognition, feeding behavior, and neuroendocrine function. It acts through three G-protein-coupled receptors: GALR1, GALR2, and GALR3. Dysregulation of galanin signaling has been implicated in neurological disorders, metabolic conditions, and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer's Disease Galanin overexpression in the basal forebrain may contribute to cholinergic neuron degeneration and cognitive decline. Evidence from postmortem brain studies and animal models (e.g., PubMed PMID: 14517595).
Epilepsy Galanin has anticonvulsant effects; reduced GAL expression or receptor dysfunction may increase seizure susceptibility. Studies in GAL knockout mice show increased seizure severity (PubMed PMID: 11487658).
Depression Galanin modulates serotonin and norepinephrine systems; altered GAL signaling is linked to depressive-like behaviors. Genetic association studies and animal models (PubMed PMID: 17632527).
Breast Cancer Galanin and its receptors are overexpressed in breast cancer tissues, potentially promoting tumor growth and metastasis. Immunohistochemistry and mRNA analysis in tumor samples (PubMed PMID: 10417684).
Obesity Galanin stimulates food intake and fat deposition; GAL gene variants may influence body weight regulation. Human genetic association studies (PubMed PMID: 10417684).

Expression Profile

Tissue Expression
Tissue nTPM level
Brain High Highest expression in hypothalamus, amygdala, and basal forebrain.
Gastrointestinal Tract Moderate Expressed in enteric neurons and endocrine cells.
Pancreas Low Present in islet cells, involved in insulin regulation.
Adrenal Gland Low Expression in medullary chromaffin cells.
Testis Low Detected in Leydig cells.
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (Neuroblastoma) High Neuronal-like cells; used for galanin signaling studies.
MCF-7 (Breast Cancer) Moderate Galanin receptor expression observed.
Caco-2 (Colorectal) Low Minimal expression.
HepG2 (Liver) Low Not typically expressed.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs948854 (promoter variant) SNP Allele frequency ~0.3 (1000 Genomes) May alter GAL expression; associated with psychiatric disorders in some studies.
rs694066 (intronic variant) SNP Allele frequency ~0.4 No known functional effect.
Missense variants (rare) SNP Very rare (<0.01) Potential impact on peptide processing or receptor binding; not well characterized.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in GAL are rare and may lead to reduced galanin production, potentially increasing seizure susceptibility and altering pain perception.

Gain of Function (GOF)

Gain-of-function mutations are not well documented; overexpression of GAL in certain cancers may act as a gain-of-function at the tissue level.

Dominant Negative (DN)

No dominant-negative mutations have been reported for GAL.

Gene Ontology (GO)

• neuropeptide hormone activity • G protein-coupled receptor binding
• regulation of feeding behavior • neurotransmitter secretion
• synaptic transmission • inflammatory response

Pathways

Galanin receptor signaling pathway
Neuropeptide signaling pathway
Regulation of insulin secretion
Pain modulation pathway

Protein Summary

Galanin is a 30-amino acid neuropeptide (in humans) derived from preprogalanin. It is amidated at the C-terminus and contains a conserved N-terminal region essential for receptor binding. Galanin interacts with three GPCRs (GALR1-3) to modulate intracellular signaling cascades, including inhibition of adenylate cyclase and activation of MAPK pathways. It is involved in diverse physiological functions, including nociception, learning and memory, feeding, and neuroendocrine regulation. In pathological conditions, galanin can exert neuroprotective or neurotoxic effects depending on context.

Related Products

Product name Cat.No. Species Gene ID
GAL Knockout HEK293T Cell Line EDJ-KQ97 Human 51083 Details Get a Quote
GALR1 Knockout HEK293 Cell Line EDJ-KQ1116 Human 2587 Details Get a Quote
ITGAL Knockout HEK293 Cell Line EDJ-KQ1350 Human 3683 Details Get a Quote
GAL Knockout HEK293 Cell Line EDJ-KQ2048 Human 51083 Details Get a Quote
LGALS9C Knockout HEK293 Cell Line EDJ-KQ2160 Human 654346 Details Get a Quote
LGALS1 Knockout HEK293 Cell Line EDJ-KQ2283 Human 3956 Details Get a Quote
ST6GALNAC3 Knockout HEK293 Cell Line EDJ-KQ2432 Human 256435 Details Get a Quote
LGALS3BP Knockout HEK293 Cell Line EDJ-KQ2621 Human 3959 Details Get a Quote
GALR2 Knockout HEK293 Cell Line EDJ-KQ2780 Human 8811 Details Get a Quote
GALNT13 Knockout HEK293 Cell Line EDJ-KQ3008 Human 114805 Details Get a Quote
LGALS8 Knockout HEK293 Cell Line EDJ-KQ3067 Human 3964 Details Get a Quote
GALK1 Knockout HEK293 Cell Line EDJ-KQ3079 Human 2584 Details Get a Quote
C1GALT1 Knockout HEK293 Cell Line EDJ-KQ3097 Human 56913 Details Get a Quote
ST6GAL1 Knockout HEK293 Cell Line EDJ-KQ3167 Human 6480 Details Get a Quote
GALR3 Knockout HEK293 Cell Line EDJ-KQ3307 Human 8484 Details Get a Quote
Displaying Records 1 To 15 Of 393 Records
Contact Us
*
*
*
*
How did you hear about us: